Catalyst Wire Dossier Catalyst Wire Dossier

Nepafenac 0.3%

nepafenac · Alcon
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nepafenac 0.3%, covering 2018-04-04 to 2018-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo [NA]

See pricing